Selected research
Industry Research
Consumer Healthcare Drug Industry Research Report 2026
Market perspective
The global Consumer Healthcare Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Consumer Healthcare Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Consumer Healthcare Drug market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Consumer Healthcare Drug market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Consumer Healthcare Drug include Takeda, Teva, Shanghai Pharmaceuticals, Sanofi, Johnson & Johnson, Merck & Co., Pfizer, Hualan Bio and North China Pharmaceutical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Consumer Healthcare Drug market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Consumer Healthcare Drug.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Consumer Healthcare Drug Market by Company
Takeda
Teva
Shanghai Pharmaceuticals
Sanofi
Johnson & Johnson
Merck & Co.
Pfizer
Hualan Bio
North China Pharmaceutical
Hengrui Medicine
GlaxoSmithKline
Bayer
AbbVie
Sinopharm Group
Livzon Group
Fosun Pharma
East China Medicine
CR Pharmaceutical
Consumer Healthcare Drug Segment by Type
Patch
Oral Liquid
Solid Preparations
Other
Consumer Healthcare Drug Segment by Application
Hospital
Retail Pharmacy
Other
Consumer Healthcare Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Consumer Healthcare Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Patch
- Oral Liquid
- Solid Preparations
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Takeda
- Teva
- Shanghai Pharmaceuticals
- Sanofi
- Johnson & Johnson
- Merck & Co.
- Pfizer
- Hualan Bio
- North China Pharmaceutical
- Hengrui Medicine
- GlaxoSmithKline
- Bayer
- AbbVie
- Sinopharm Group
- Livzon Group
- Fosun Pharma
- East China Medicine
- CR Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Consumer Healthcare Drug by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Patch
- 2.2.3 Oral Liquid
- 2.2.4 Solid Preparations
- 2.2.5 Other
- 2.3 Consumer Healthcare Drug by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Consumer Healthcare Drug Breakdown Data by Type
- 3.1 Global Consumer Healthcare Drug Historic Market Size by Type (2021-2026)
- 3.2 Global Consumer Healthcare Drug Forecasted Market Size by Type (2027-2032)
4 Consumer Healthcare Drug Breakdown Data by Application
- 4.1 Global Consumer Healthcare Drug Historic Market Size by Application (2021-2026)
- 4.2 Global Consumer Healthcare Drug Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Consumer Healthcare Drug Market Perspective (2021-2032)
- 5.2 Global Consumer Healthcare Drug Growth Trends by Region
- 5.2.1 Global Consumer Healthcare Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Consumer Healthcare Drug Historic Market Size by Region (2021-2026)
- 5.2.3 Consumer Healthcare Drug Forecasted Market Size by Region (2027-2032)
- 5.3 Consumer Healthcare Drug Market Dynamics
- 5.3.1 Consumer Healthcare Drug Industry Trends
- 5.3.2 Consumer Healthcare Drug Market Drivers
- 5.3.3 Consumer Healthcare Drug Market Challenges
- 5.3.4 Consumer Healthcare Drug Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Consumer Healthcare Drug Players by Revenue
- 6.1.1 Global Top Consumer Healthcare Drug Players by Revenue (2021-2026)
- 6.1.2 Global Consumer Healthcare Drug Revenue Market Share by Players (2021-2026)
- 6.2 Global Consumer Healthcare Drug Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Consumer Healthcare Drug Head Office and Area Served
- 6.4 Global Consumer Healthcare Drug Players, Product Type & Application
- 6.5 Global Consumer Healthcare Drug Manufacturers Established Date
- 6.6 Global Consumer Healthcare Drug Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Consumer Healthcare Drug Market Size (2021-2032)
- 7.2 North America Consumer Healthcare Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Consumer Healthcare Drug Market Size by Country (2021-2026)
- 7.4 North America Consumer Healthcare Drug Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Consumer Healthcare Drug Market Size (2021-2032)
- 8.2 Europe Consumer Healthcare Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Consumer Healthcare Drug Market Size by Country (2021-2026)
- 8.4 Europe Consumer Healthcare Drug Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Consumer Healthcare Drug Market Size (2021-2032)
- 9.2 Asia-Pacific Consumer Healthcare Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Consumer Healthcare Drug Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Consumer Healthcare Drug Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Consumer Healthcare Drug Market Size (2021-2032)
- 10.2 South America Consumer Healthcare Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Consumer Healthcare Drug Market Size by Country (2021-2026)
- 10.4 South America Consumer Healthcare Drug Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Consumer Healthcare Drug Market Size (2021-2032)
- 11.2 Middle East & Africa Consumer Healthcare Drug Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Consumer Healthcare Drug Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Takeda
- 12.1.1 Takeda Company Information
- 12.1.2 Takeda Business Overview
- 12.1.3 Takeda Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.1.4 Takeda Consumer Healthcare Drug Product Portfolio
- 12.1.5 Takeda Recent Developments
- 12.2 Teva
- 12.2.1 Teva Company Information
- 12.2.2 Teva Business Overview
- 12.2.3 Teva Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.2.4 Teva Consumer Healthcare Drug Product Portfolio
- 12.2.5 Teva Recent Developments
- 12.3 Shanghai Pharmaceuticals
- 12.3.1 Shanghai Pharmaceuticals Company Information
- 12.3.2 Shanghai Pharmaceuticals Business Overview
- 12.3.3 Shanghai Pharmaceuticals Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.3.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio
- 12.3.5 Shanghai Pharmaceuticals Recent Developments
- 12.4 Sanofi
- 12.4.1 Sanofi Company Information
- 12.4.2 Sanofi Business Overview
- 12.4.3 Sanofi Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.4.4 Sanofi Consumer Healthcare Drug Product Portfolio
- 12.4.5 Sanofi Recent Developments
- 12.5 Johnson & Johnson
- 12.5.1 Johnson & Johnson Company Information
- 12.5.2 Johnson & Johnson Business Overview
- 12.5.3 Johnson & Johnson Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.5.4 Johnson & Johnson Consumer Healthcare Drug Product Portfolio
- 12.5.5 Johnson & Johnson Recent Developments
- 12.6 Merck & Co.
- 12.6.1 Merck & Co. Company Information
- 12.6.2 Merck & Co. Business Overview
- 12.6.3 Merck & Co. Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.6.4 Merck & Co. Consumer Healthcare Drug Product Portfolio
- 12.6.5 Merck & Co. Recent Developments
- 12.7 Pfizer
- 12.7.1 Pfizer Company Information
- 12.7.2 Pfizer Business Overview
- 12.7.3 Pfizer Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.7.4 Pfizer Consumer Healthcare Drug Product Portfolio
- 12.7.5 Pfizer Recent Developments
- 12.8 Hualan Bio
- 12.8.1 Hualan Bio Company Information
- 12.8.2 Hualan Bio Business Overview
- 12.8.3 Hualan Bio Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.8.4 Hualan Bio Consumer Healthcare Drug Product Portfolio
- 12.8.5 Hualan Bio Recent Developments
- 12.9 North China Pharmaceutical
- 12.9.1 North China Pharmaceutical Company Information
- 12.9.2 North China Pharmaceutical Business Overview
- 12.9.3 North China Pharmaceutical Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.9.4 North China Pharmaceutical Consumer Healthcare Drug Product Portfolio
- 12.9.5 North China Pharmaceutical Recent Developments
- 12.10 Hengrui Medicine
- 12.10.1 Hengrui Medicine Company Information
- 12.10.2 Hengrui Medicine Business Overview
- 12.10.3 Hengrui Medicine Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.10.4 Hengrui Medicine Consumer Healthcare Drug Product Portfolio
- 12.10.5 Hengrui Medicine Recent Developments
- 12.11 GlaxoSmithKline
- 12.11.1 GlaxoSmithKline Company Information
- 12.11.2 GlaxoSmithKline Business Overview
- 12.11.3 GlaxoSmithKline Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.11.4 GlaxoSmithKline Consumer Healthcare Drug Product Portfolio
- 12.11.5 GlaxoSmithKline Recent Developments
- 12.12 Bayer
- 12.12.1 Bayer Company Information
- 12.12.2 Bayer Business Overview
- 12.12.3 Bayer Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.12.4 Bayer Consumer Healthcare Drug Product Portfolio
- 12.12.5 Bayer Recent Developments
- 12.13 AbbVie
- 12.13.1 AbbVie Company Information
- 12.13.2 AbbVie Business Overview
- 12.13.3 AbbVie Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.13.4 AbbVie Consumer Healthcare Drug Product Portfolio
- 12.13.5 AbbVie Recent Developments
- 12.14 Sinopharm Group
- 12.14.1 Sinopharm Group Company Information
- 12.14.2 Sinopharm Group Business Overview
- 12.14.3 Sinopharm Group Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.14.4 Sinopharm Group Consumer Healthcare Drug Product Portfolio
- 12.14.5 Sinopharm Group Recent Developments
- 12.15 Livzon Group
- 12.15.1 Livzon Group Company Information
- 12.15.2 Livzon Group Business Overview
- 12.15.3 Livzon Group Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.15.4 Livzon Group Consumer Healthcare Drug Product Portfolio
- 12.15.5 Livzon Group Recent Developments
- 12.16 Fosun Pharma
- 12.16.1 Fosun Pharma Company Information
- 12.16.2 Fosun Pharma Business Overview
- 12.16.3 Fosun Pharma Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.16.4 Fosun Pharma Consumer Healthcare Drug Product Portfolio
- 12.16.5 Fosun Pharma Recent Developments
- 12.17 East China Medicine
- 12.17.1 East China Medicine Company Information
- 12.17.2 East China Medicine Business Overview
- 12.17.3 East China Medicine Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.17.4 East China Medicine Consumer Healthcare Drug Product Portfolio
- 12.17.5 East China Medicine Recent Developments
- 12.18 CR Pharmaceutical
- 12.18.1 CR Pharmaceutical Company Information
- 12.18.2 CR Pharmaceutical Business Overview
- 12.18.3 CR Pharmaceutical Revenue in Consumer Healthcare Drug Business (2021-2026)
- 12.18.4 CR Pharmaceutical Consumer Healthcare Drug Product Portfolio
- 12.18.5 CR Pharmaceutical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst